CStone Pharmaceuticals (2616.HK) stock: key figures, P/E, revenue and dividend
Health Care · China · ISIN KYG2588M1006
CStone Pharmaceuticals financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 407.00 m CNY | 273.27 m CNY |
| Gross profit | 240.00 m CNY | 51.51 m CNY |
| EBIT | -91.00 m CNY | -439.15 m CNY |
| Net income | -91.00 m CNY | -443.52 m CNY |
| Diluted EPS – continuing operations | -0.07 CNY | -0.30 CNY |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CStone Pharmaceuticals
CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, and relapsed or refractory natural killer/T cell lymphoma; GAVRETO (pralsetinib), a RET inhibitor to treat patients with advanced or metastatic RET-mutant medullary and RET fusion-positive thyroid cancers, as well as NSCLC and multiple tumors; and AYVAKIT (avapritinib), a KIT/PDGFRA inhibitor, has been approved by the China NMPA for the treatment of adults with unresectable or metastatic GIST harboring a PDGFRA exon 18 mutation, including PDGFRA D842V mutations. It has strategic partnerships with Pfizer, Sanofi, Hengrui, 3SBio Inc., Allist, Ewopharma, Pharmalink, SteinCares, and Gentili. CStone Pharmaceuticals was incorporated in 2015 and is headquartered in Suzhou, China.
More stocks
- Xian Xice Testing Technology Co. Ltd. A (301306.SZ)
- Loma Negra Compania Industrial Argentina SA ADR (LOMA)
- Saf-Holland Se (SFQ.DE)
- ASRock Inc (3515.TW)
- Guangzhou Frontop Digital Creative Technology Co. Ltd. A (301313.SZ)
- Polenergia SA (PEP.WA)
- Lindab International AB (LIAB.ST)
- KFORCE INC (KFRC)
- Max Zipper Co Ltd (8932.TWO)
- Sumavision Technologies (300079.SZ)
- Guangzhou Metro Design And Research (003013.SZ)
- STANDARD MOTOR PRODUCTS, INC. (SMP)
Not investment advice. All data without warranty, price as of 04.11.2026. Details in the risk notice.